XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows used in Operating Activities    
Net loss $ (16,010,287) $ (13,828,622)
Adjustments to reconcile net loss to net cash used in operations:    
Stock-based compensation 2,785,470 2,965,177
Changes in non-cash working capital balances related to operations:    
Incentive and tax receivables (2,478,750) (1,509,202)
Prepaid expenses and deposits 57,030 195,439
Accounts payable (331,002) 126,402
Accrued liabilities 302,205 1,062,755
Deferred grant income 487,111 0
Net cash used in operating activities (15,188,223) (10,988,051)
Cash Flows provided by Financing Activities    
Issuance of common shares 61,934,439 15,365,492
Share issue costs (1,134,697) 0
Proceeds from exercise of stock options 998,802 0
Net cash provided by financing activities 61,798,544 15,365,492
Increase in cash and cash equivalents during the period 46,610,321 4,377,441
Cash and cash equivalents, beginning of period 29,249,018 22,185,630
Cash and cash equivalents, end of period $ 75,859,339 $ 26,563,071